SURJ@UQ by Susan Rowland
Science Undergraduate 
Research Journal at 
The University of Queenland
Issue 2 | 2015
The Art of  Science
Article written by Jacinta Bowler
Everything can be beautiful if the right artist is put to 
the job. John Griffin works as a microscopy officer at 
the Institute for Molecular Biosciences, and he sees his 
precise science as an art form.
Microscopy uses high-end microscopes to help scientists 
analyse the micro-world. John’s work speaks for itself – 
an embryo in development, an artery, even the guts of a 
mouse can be beautiful when John works his magic. His 
images are expertly edited and manipulated, creating 
striking close-up displays.
John’s photography does have an important work role 
inside the laboratory as well. His work allows biologists 
to see what is going on inside their transgenic mouse, 
or how zebra fish embryos mature, but his work can 
be stretched across nearly all aspects of science. “I have 
worked with geologists, biologists, physicists and chem-
ists. Microscopy can be used to help so many different 
areas of science. I had been looking for a way to marry 
art and science together and microscopy does it beauti-
fully for me.”
His favourite thing to look at under the microscope? “It’s 
actually pond scum. I find it endlessly fascinating. There 
are so many different tiny organisms running around. 
Because of the diversity of those sorts of water bodies 
there are many different types of creatures, all crammed 
into one place.”
Art and science are rarely on the same page, but that is 
why John excels at what he does. He loves microscopy 
because he gets to blur the lines, so to speak. His images 
help even those who do not enjoy science to discover the 
exciting micro-world around us. 
Mouse embryo used in developmental studies
The image on the front cover, and all images on the 
next three pages were created by John Griffin through 
the Institute for Molecular Bioscience at UQ. 
 
Permission to use his photos was granted.
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John is currently a Microscopy Imaging Officer at the 
Institute for Molecular Bioscience (IMB) at UQ. He 
has worked in the labs of Professor Jennifer Stow and 
Assistant Professor Rohan Teasdale, also at the IMB. 
Prior to coming to UQ, John worked in the lab of 
Michael Davidson at Florida State University, taught 
high-school science, sold yo-yos and worked at the 
door of an alternative music club. In his free time he 
enjoys cooking and photography, and spends way too 
much time playing Skyrim.
A robber fly under the microscope at 16x magnification
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Editor’s Note
Welcome to the second edition of SURJ@UQ. 
In this edition we are showcasing six terrific articles from UQ students, as well as some beautiful photos from 
John Griffin. We have three biotechnology articles in this issue: Anika Merley discusses the prospects and perils 
of genetic engineering, Evan Owens examines new treatments for HIV, and Dolyce Low reports on her vampire 
bat venom research. We have a fascinating piece from Celine Santiago in which she asks “Is sickness all in your 
mind?”, while Jacinta Kong reveals the secrets of the honours student. Finally, Thisun Piyasena gives us a round-
up of some of the most bizarre research papers ever – including an explosive reveal of the pressure generated 
when a penguin poops. 
This edition of SURJ would not have been possible without the help of three dedicated and highly skilled UQ 
students - Tze Chen Lim, Zac Pross, and Jacinta Bowler. 
Chen and Zac completed their honours projects in my group in 2013. They ran and evaluated a peer-mentoring 
program in which the student authors for SURJ wrote pieces and then helped each other improve. Zac and Chen 
also personally mentored our student authors and Zac has continued to volunteer as an editor for SURJ through-
out 2014. As a consequence of Zac and Chen’s hard work we now have this edition of SURJ, and another edition 
well on its way. 
Jacinta Bowler is an undergraduate science/journalism student who has done all the page production for this 
beautiful edition. She has been working on the project throughout 2014 as a School of Chemistry and Molecular 
Biosciences Intern, and she will get well-deserved UQ Advantage recognition for it when she graduates. Jacinta 
will be going to The University of Toronto in 2015 on exchange. We wish her well, but we will miss her miracu-
lous capability with InDesign.
If you are a UQ student and you would like to work on future editions of SURJ as a writer, editor, or designer, let 
me know (s.rowland1@uq.edu.au). Team SURJ is always keen to welcome new members. 
We hope you enjoy this edition!
Susan Rowland 
Tze Chen Lim, Zac Pross, Susan Rowland and Jacinta Bowler - Team SURJ
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Biotechnology: Bringing Home the 
(Genetically Engineered) Bacon
By Anika Merkley
The last pharaoh of Ancient Egypt, 
Cleopatra VII, probably sat down to a 
feast of delicacies every evening – she 
was after all, the pharaoh. What she 
might not have realised was that many 
of these delicacies were the products of 
biotechnology.
Even though the term “biotechnology” 
was coined only recently, humans have 
exploited the fundamentals of this 
branch of science since 10,000 B.C. 
Our ability to manipulate biological 
systems to improve our quality of life 
has been pivotal to our dominating 
history; and, since the key to a civilisa-
tion’s heart is through its stomach, hu-
mans have always been very interested 
in controlling the biological systems 
that produce food.
The Agricultural Revolution saw farm-
ers starting to use seeds of only the 
most hardy, healthy, and high-yielding 
plants. Later, the crossing of these 
plants was discovered to accelerate the 
acquisition of desired traits; for exam-
ple, crossing a drought-resistant plant 
with a disease-resistant plant may pro-
duce a plant with resistances to both. 
With some luck, in a few generations 
a stronger plant population could be 
established. Such selective breeding 
was the earliest form of genetic ma-
nipulation. 
Fast forward to 3000 B.C., where an 
ancient Egyptian pharaoh gorges on 
his nightly feast of newly harvested 
vegetables. Thanks to selective breed-
ing, the harvest is bigger than when 
he was a child. He slugs a few pints of 
beer to wash down his healthy side of 
bread. Although this beer and bread 
are very different to the ones we can 
buy today both were made in much 
the same way as they are now using 
fermentation.
Fermentation is possibly the earliest 
form of biotechnology. It occurs when 
tiny, single-celled organisms called 
yeast convert sugars into ethanol and/
or carbon dioxide. When grains are 
mixed with water (and often fruit for 
extra flavour in Ancient Egypt), yeasts 
ferment the sugars, producing a tasty 
and nutritious drink. In dough, the 
carbon dioxide released by yeast causes 
the gluten to stretch and the bread to 
rise. 
Beer has remained an important part 
of society since Ancient Egypt. In 
medieval and early-modern Europe, 
high-density human populations 
caused so much faecal contamination 
of public water reserves that drinking 
fresh water often resulted in disease. 
The ethanol in beer, however, essential-
ly sterilised the drink, making it a safe 
source of fluids. There was one small 
difference between beer in Ancient 
Egypt and medieval Europe: medieval 
beer had a greater concentration of 
alcohol, which meant intoxication was 
a daily event. Drunkenness was, unsur-
prisingly, preferable to cholera. Many 
historians regard beer as an essential 
component to the creation of civili-
sation; it provides nutrition, prevents 
disease, and enriches dinner parties. 
All thanks to tiny yeast cells!
Thousands of years since the fall of 
Ancient Egyptian civilisation, I sit 
down to my own dinner. My bread and 
beer were fermented and my vegeta-
bles were grown from selectively bred 
plants. Not much has changed since 
Ancient Egypt - or has it?
Biotechnology is both one of the new-
est and the oldest branches of science. 
Modern biotechnologists are always 
attempting to improve on past advanc-
es. Agriculture has progressed from 
simple cross-breeding to the modern 
manipulation of DNA. Instead of 
waiting decades to develop the ‘perfect’ 
plant by continuous crossing of desir-
able traits, scientists can combine the 
desired genes in months using genetic 
engineering. The resultant plants are 
genetically modified organisms, or 
GMOs.
To make a GMO the genes of inter-
est must first be identified. This isn’t 
a difficult task with modern sequenc-
ing techniques. Once the genes are 
sequenced, they can be isolated and 
amplified. After this they are inserted 
into the plant. The result? A plant that 
expresses new, advantageous proteins. 
Some of these proteins don’t even 
originate from plants. A fish gene, for 
example, has been added to tomatoes 
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Micrograph showing ground glass hepato-
cytes, which are seen in chronic hepatitis B 
infections
to increase frost tolerance!
This seems like an obvious solution for 
world hunger, add a few genes to com-
mon plants to increase nutrition, yield, 
and resilience. Ancient Egypt’s farm-
ers were attempting to do the same 
(albeit with simple cross-breeding) 
to feed their own increasing popula-
tion. Nonetheless, the public have not 
received GMOs with open arms.
Several controversial papers have 
caused a surge of panic in the media, 
despite being dismissed by the aca-
demic community. In 2012, headlines 
across the world warned of a French 
study linking GM maize to cancer. The 
study by Gilles-Eric Seralini had con-
cluded that, when fed to rats, a strain 
of maize – genetically modified by 
Monsanto to be resistant to Roundup 
herbicide – caused tumours to develop. 
The researchers involved in the study 
held a press conference for journalists 
on the condition that a confidentiality 
agreement was signed, preventing the 
journalists from discussing the research 
with outside experts. After its public 
release, the paper was dismissed by the 
scientific community as being poorly 
designed and inconclusive.
Scientists claimed the rat line used 
had a high tendency to develop 
tumours naturally, so it was an inap-
propriate model. The statistical power 
of the study (the number of rats in 
each study) was insufficient; and the 
statistical analysis was questionable. 
Before the academic community had a 
chance to condemn the study, howev-
er, headlines warned of carcinogenic 
maize – a dangerous “Frankenstein 
food” produced by scientists trying to 
play God. 
For most members of the public, the 
general media is their only exposure to 
scientific news. With most academic 
criticisms of the study not escaping 
the scientific community, it’s not 
surprising that the public fears the 
introduction of GM foods. While 
controversy and fear sells newspa-
pers, it’s important that the public is 
exposed to both sides of the argument 
– something that did not happen with 
the Seralini study. 
But there is headway being made. Ear-
lier this year, Mark Lynas, an environ-
mental activist who played a key role 
in “demonising” genetically modified 
crops, apologised at the Oxford Farm-
ing Conference. Lynas admitted he 
was “penning screeds in the Guardian 
attacking the science of GM – even 
though I had done no academic re-
search on the topic.” The “anti-science 
movement” led to the banning of GM 
foods in Europe, Asia and Africa. This 
includes blocking the release of a more 
nutritious rice strain developed to pre-
vent blindness resulting from vitamin 
A deficiency, an obstructive act which 
Lynas now describes as “immoral and 
inhumane.” Lynas was able to change 
his mind after he “discovered science.” 
Having learned to read and evaluate 
scientific literature, Lynas realised that 
the anti-GM claims were unsubstan-
tiated. He now admits “people have 
died from choosing organic, but no 
one has died from eating GM.” He 
played a strong part in the condemna-
tion of GM foods, but hopefully Lynas 
can now play an even stronger role in 
educating the public on the benefits, 
allowing them to make their own 
opinions based on facts, rather than 
fear. 
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Increasing food supply is not the only benefit to be gained 
from biotechnology and GMOs. If you’ll remember, I was 
sitting at my dinner table. While I eat, I’m perusing infor-
mation on my next holiday destination, China, when I read 
that Hepatitis B is endemic there. Hepatitis B is a virus that 
can cause serious, chronic liver disease, sometimes resulting 
in liver failure. Luckily for me, a vaccination exists, provid-
ing me with immunity. But how was the vaccination made? 
To the rescue, once again, is yeast!
The Hepatitis B vaccination contains a viral surface protein. 
Cells of the immune system recognise the surface pro-
tein,  produce antibodies that bind specifically to it, and so 
increase clearance of the pathogen. If I am later exposed to 
the virus, my immune system will be much faster at recog-
nising and quickly eliminating the invasion, before it causes 
serious disease. Isolating the protein from the virus is, 
however, a complicated and time-consuming task. Instead, 
much like adding foreign genes into plants, the gene for the 
protein can be introduced into yeast cells which then act 
as tiny protein factories. Scientists simply have to harvest 
the protein and add it to the solution that will be injected 
during a vaccination. By adding the genes, it’s possible for 
yeast cells to produce almost any protein, which is useful for 
the development of vaccinations and other pharmaceuticals. 
Biotechnology is useful for more than just protein pro-
duction. Many microbes are capable of breaking down or 
converting substances that man-made technology can-
not, using enzymes, and microbe metabolism can be used 
to break down pollutants. Polychlorinated biphenyls (or 
PCBs) are ubiquitous and persistent organic pollutants that 
were released mostly from transformers and other electrical 
equipment manufactured before 1980. In early 2013, PCBs 
were classified as class I carcinogens; they are also known 
to cause skin and liver disease, cardiovascular problems, and 
immune suppression. 
Despite their extreme resistance to environmental or 
metabolic degradation, PCBs can be broken down into less 
harmful products by a small number of microbes. Although 
far from being industrialised, these microbes can potentially 
be used to “clean” electronic waste before disposal, limiting 
release of the harmful substance. In certain locations, they 
may even be able to clean up environmental PCBs. Scien-
tists are far from being able to engineer a soup of self-reg-
ulating enzymes that can complete the process outside of 
the cell; but in the future, it may be possible to break down 
contaminated waste using microbial processing plants.
Biotechnology has come a long way since the days of An-
cient Egypt, but it has the potential to go so much further. 
Perhaps, if the branch of science is no longer treated as a 
hostile enemy by members of the public, biotechnology 
will be our future. Microbial plants will process all waste, 
breaking down toxic or polluting substances; individuals 
living in remote or arid areas will grow their own hardy, 
highly-nutritious grains and crops; infectious diseases will 
be eradicated thanks to vaccination; and all among a beau-
tiful environment of bright, genetically engineered flowers 
and plants. 
Biotechnology is not without risks and many branches of 
the discipline are morally grey, however there is no ques-
tion that biotechnology can bring us a brighter future. The 
question is: will we let it?
About the Author
Anika Merkley just graduated from UQ with 
a Bachelor of Biomedical Science.  She com-
pleted her honours project at the Queensland 
Children’s Medical Research Institute, study-
ing asthma.  Not one to be settled in a single 
area, Anika is about to begin a Master in Public 
Health, with dreams of working with the World 
Health Organisation in disaster response.  She 
has a passion for spreading the word of science, 
and as an avid writer and reader, she can usually 
be found writing about books, smelling books, or 
writing about the science behind smelling books.
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Dracula’s children: 
Characterisation of  the common vampire bat venom
By Dolyce Low
Diagram illustrating the process of how the amino acid sequences of venom components 
are obtained from the venom. D. rotundus venom was treated and sequenced by a LC-MS/
MS machine. The resultant protein sequences were compared with those in online protein 
catalogues to determine their function.
When word spread that Europeans 
had discovered a bat that survived 
solely on the blood of its live mam-
malian victims, it didn’t take long 
for people to draw parallels to the 
fictional haematophagous monster 
invading their 17th century children’s 
nightmares. Vampire bats have since 
inspired caution if not downright fear 
in most people, but new research may 
help shine a new light on these noc-
turnal blood-suckers.
All three species of vampire bat are 
confined to Central and South Amer-
ica. They are exceptionally adapted 
towards haematophagy (blood-feed-
ing) – tracking their prey using their 
extraordinary long-range vision, 
olfaction, hearing and echo-location. 
Desmodus rotundus, the common vam-
pire bat, has the largest population and 
is most frequently used in vampire bat 
research. 
Thanks to reinforced limbs, vampire 
bats are the only bats that can sneak 
up on their prey from the ground us-
ing quadrupedal walking and jumping. 
Their heat and mechanical receptors 
tell the bats where they can find the 
target’s blood; and their sharp teeth 
subsequently make tiny incisions in 
the skin. The victim’s defenses try to 
rapidly plug the wound, except the 
vampire bat has a venomous counter-
measure. That’s right, vampire bats are 
venomous.
A bite from D. rotundus won’t wreak 
havoc on your nervous system like a 
bite from a poisonous snake; think 
more along the lines of how leech 
venom keeps your wound oozing long 
after you’ve bashed the leech away. 
Similarly, D. rotundus keep their food 
flowing by interfering with the victim’s 
blood-clotting response.
Because of this property, D. rotun-
dus venom has been researched for 
its potential to destroy stroke-caus-
ing blood-clots. So far, these studies 
have focused on two components of 
the venom: Plasminogen Activators 
(DSPAs) and Draculin (a name that 
suggests vampire bats may never shake 
their mythical roots).
Recognising that common vampire 
bat venom had yet to be fully char-
acterised, Associate Professor Brian 
Fry and I collaborated with an inter-
national team of researchers to close 
the research gap. We have discovered 
many new components in D. rotundus 
venom; all of which aid the bat’s leech-
like lifestyle, and all holding great 
potential for drug development.
But first, how does vampire bat 
venom stop blood-clots?
In order for D. rotundus to feed on its 
prey’s blood effectively, it must be able 
to interfere with its victim’s typical 
blood coagulation response (coagula-
tion cascade). 
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SDS-PAGE: An electric current is passed through the polyacrylamide gel causing proteins in 
the venom to migrate downwards according to their size (molecular weight).
Several blood-flow-reducing process-
es occur within minutes of an injury 
to a mammal’s skin or blood vessels: 
the blood vessels constrict (vasocon-
striction) to reduce flow to the site 
of injury, and cells known as platelets 
are activated to help plug the wound. 
Simultaneously, another group of 
blood coagulation enzymes and factors 
activate the insoluble plasma protein 
fibrin, which stabilises the platelet plug 
to form a solid fibrin blood clot. 
A separate physiological balancing 
system known as the fibrinolytic 
pathway is then activated to remove 
the clot after it has served its purpose. 
Specifically, an inactive enzyme called 
plasminogen (which was incorporated 
into the clot as it formed) is slowly 
converted into the active enzyme plas-
min by plasminogen activators. This 
breaks down the clot’s fibrin mesh 
from within.
Prior to our study, D. rotundus venom 
was thought to interfere with this co-
agulation process in three ways. Firstly, 
Draculin prevents the conversion 
of fibrinogen to fibrin by inhibiting 
factors IXa and Xa of the coagulation 
mechanism. Secondly, D. rotundus 
venom contains plasminogen activa-
tors called DSPAs; these thrombolytic 
agents keep the blood flowing by 
activating the prey’s own plasminogen. 
Lastly, some scholars had noted that 
D. rotundus venom seems to sabotage 
the platelets’ ability to bond to foreign 
substances (and hence to plug up an 
injury site). 
Our study is the first characterise the 
effective components of D. rotundus 
venom using both a transcriptomic 
and proteomic approach. We identified 
the highly active genes that contribute 
to the venom proteome and also ob-
served the molecular evolution of the 
proteins that these genes encoded. In 
doing so we have greatly advanced our 
understanding of the venom’s history 
and potential.
Bioinformatics:
In this study, we also wanted to inves-
tigate whether any of the D. rotundus 
venom components discovered in the 
2D gel electrophoresis were under a 
neutral, negative, or positive selection 
regime. To do this, we needed to know 
the history of mutations that have led 
to the components’ current states, but 
a sequence’s full family (phylogenetic) 
tree is usually unknown.
Since we have information on se-
quences genetically related (homo-
logs) to the D. rotundus sequences 
of interest, we used Markov Chain 
Monte Carlo (MCMC) simulations 
to estimate the venom components’ 
phylogenetic trees. For each venom 
component of interest, the final tree 
structures were constructed by look-
ing at the final MCMC tree sets and 
determining the majority structure at 
each step.
We investigated which selection 
regimes were most likely to explain the 
Generating family (phylogenetic) trees
A string of three DNA nucleobases (cytosine (C), guanine (G), adenine (A) and thymine (T)) is called a codon. Co-
dons instruct the body’s protein-building machinery to add a particular amino acid to a growing protein chain. For 
instance, the codon TCA codes for the amino acid proline; GCT for alanine; CTG for leucine; and so on. Sometimes 
mistakes called mutations can occur where a codon is incorrectly read or copied. Not all mutations are bad though; most 
amino acids are encoded by more than one base combination, and so many mutations are silent in that they don’t end 
up changing the produced amino acid. If a particular DNA sequence is functionally important to a species’ survival, any 
non-silent mutations within such a sequence would more likely decrease rather than increase the evolutionary fitness of 
its host; therefore, while a DNA sequence remains functionally important, natural selection will negatively select against 
non-silent mutations – allowing an accumulation of silent mutations.
But say a species migrates, and in the new fitness conditions an organism experiences a new, non-silent mutation that 
happens to now confer an advantage. This organism will more likely survive and reproduce. Positive selection is when a 
non-silent mutation confers a fitness advantage and thus becomes fixed in the population. Across a range of genetically 
related species, a sequence will reveal it is under positive selection if it exhibits an excessive amount of non-silent to 
silent mutations.
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structure of the phylogenetic trees. We 
compared models that assumed the ra-
tio of nonsynonymous to synonymous 
mutations were constant across all 
sites of a tree; to models that assumed 
neutral evolution, where all sites were 
assumed to be under either negative 
or neutral evolution; to models that 
assumed positive selection. Likelihood 
ratio tests were used to determine the 
best fitting models, which revealed the 
evolutionary regime acting on each 
newly found D. rotundus venom com-
ponent. This allowed us to infer which 
venom components were providing an 
evolutionary advantage to D. rotundus, 
and which were not. 
What we found
For the first time, we have unveiled 
venom components never-before-seen 
in D. rotundus venom. They interfere 
with many more aspects of the typical 
mammalian injury response than was 
previously known and – coupled with 
Draculin and DSPA – are the only 
reason why D. rotundus can survive 
purely on blood.
We found numerous exciting proteins 
of interest, including proteins that can 
expand blood vessels (vasodilators – 
Calcitonin, PACAP, VIP) and alter 
blood flow; proteins that disrupt the 
electrochemical gradient in cell mem-
branes (ion channel blockers – CRiSP, 
Kunitz) and affect cell functioning; 
as well as finding proteins capable of 
multiple duties.
For instance, we found a toxin-type 
protein called Kallikrein that expands 
blood vessels, degrades fibrin clots, 
and lowers blood pressure. We found 
lipocalins that expand blood vessels 
too, but also inhibit fibrin clotting 
(through inhibition of Factor IXa and 
Thrombin) and induce allergic reac-
tions. Additionally, we found Kunitz 
peptides that have not only been doc-
umented to block ion channels, but are 
also capable of inhibiting Factors VIIa, 
Xa & IX, thrombin (anti-coagulant) 
and tissue factor (which initiates the 
coagulation cascade).
This study also investigated the molec-
ular evolution of D. rotundus venom; 
those results imply that Desmallip-
ins, Kunitz domain (I and II) and 
plasminogen activator are under the 
regime of positive selection – accu-
mulating radical mutations that have 
introduced amino acids with quite 
divergent and/or structural properties. 
Furthermore, all the positively select-
ed sites in Kunitz domain (I and II) 
and 43% of positively selected sites 
in plasminogen activator were found 
on the surface of the toxin, suggesting 
that the frequent production of sur-
face-confined mutations both con-
serves important structural or func-
tional sequences found elsewhere, and 
prevents prey animals’ ability to mount 
an immunological resistance.
What’s the significance?
The published literature on D. rotun-
dus saliva is predominantly focused on 
DSPAs, Draculin, and the rabies virus. 
With the completion of this study, we 
were the first to fully characterise D. 
rotundus secreted venom and discover 
the majority of its components. 
D. rotundus targets the coagulation 
cascade and ensures a successful feed 
by using a unique combination of 
anticoagulants, fibrinolytic agents, 
platelet aggregation inhibitors, vasodi-
lators, and more. We also showed that 
D. rotundus’ efforts to keep the blood 
flowing have resulted in a genetic arms 
race between predator and prey; our 
results suggest that surface-confined 
mutations are likely the bat’s strategy 
to evade the immune responses of prey 
animals.
With further research into these newly 
discovered venom components, one 
could easily determine their potential 
for drug design. Further information 
can be obtained from the published 
article “Dracula’s children: Molecular 
evolution of vampire bat venom”. 
About the Author
Dolyce Low is an international student from Singapore who en-
rolled in UQ’s Zoology and Marine Science in 2010. The bachelor 
program has cultivated her interest towards research and she received 
two summer research scholarships to further develop this interest.
This article on the characterization of the vampire bat (Desmodus ro-
tundus) venom is a section of her honours project that she completed 
under the supervision of A/Prof Bryan G. Fry (Venom Evolution 
Laboratory). Dolyce is now back in Singapore and is employed by 
Duke-NUS, researching bat viruses.
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For Dr. Jaleel Miyan, the famous idi-
om ‘mind over matter’ is scientifically 
accurate.
The Royal Society Fellow and Casey 
Holter Essay Prize Winner is part 
of a growing group of experts that 
challenge the standard theory of the 
blood-brain barrier. It was originally 
understood that, since the barrier pre-
vented white blood cells from entering 
the central nervous system, the im-
mune system couldn’t act on the brain 
– and vice versa.
‘Pain fibres’ send electrical signals to 
our brains after we touch something 
hot, for instance; but Dr. Miyan argues 
that these fibres play another role in 
monitoring human health. “You see 
pain fibres going through every single 
tissue in the body; every single cell has 
a pain fibre associated with them; if 
these fibres have a function below the 
threshold for pain it must be extremely 
important.”
He hypothesises that the brain uses 
a ‘negative feedback’ mechanism that 
not only detects painful stimuli, but 
also distinguishes between different 
challenges presented to the immune 
system. Once the brain knows what 
our bodies are up against, it can use 
the pain fibres to release chemical 
messengers known as neurotransmit-
ters, which can induce the sickness 
behaviours that aid our recovery. 
For years, the mechanism underlying 
the detection of host challenges by the 
immune system remained a mystery. 
The first inkling that the brain had 
some part in the immune system was 
in 1990, when Yamanaka et al. revealed 
that there was a true synaptic connec-
tion between the bone marrow and 
the brain – mediated by pain fibres. 
Bone marrow was already known 
to be responsible for the creation of 
oxygen-carrying red blood cells and 
wound-clotting platelets, but the 
flexible, internal bone tissue also has 
a hand in developing the white blood 
cells that remove bacteria and eradi-
cate viruses.
How our brain makes us better
The picture above shows a simple  
diagram of how Dr. Miyan’s proposed 
negative-feedback mechanism works. 
The brain uses what is known as a ‘set 
point’ to compare how the immune 
system is currently acting compared to 
how it would be acting under perfectly 
healthy circumstances. If the brain 
detects a ‘host challenge’ (including 
bacterial, viral or a physical challenge), 
it can tell the immune system to 
induce sickness behaviours in an effort 
to bring the body back in line with the 
set point.
Just like we would set the tempera-
ture of a thermostat, our ‘set point’ is 
determined during our mother’s third 
trimester of pregnancy and, during this 
time, can be changed depending on 
what she experiences (e.g. an infec-
tion). 
Many different diseases could be 
explained by a simple loss of balance 
in this negative feedback loop. For 
instance, in cancer, the immune system 
is over-suppressed, while people with 
autoimmune disorders have hyperac-
tive immune systems.
The nitty-gritty business of reporting 
the bad guys
The ends of pain fibres are known to 
terminate in bone marrow cells known 
as stromal cells. These cells act as a 
A Healthy Brain is a Healthy Body
By Celine Santiago
Pain fibres (blue) release neurotransmitters 
(CGRP, substance P) which interact with 
stromal cells to initiate haematopoiesis. 
Haematopoesis can generate either red 
blood cells, clotting factors, or white blood 
cells which can go on to destroy host chal-
lenges.
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niche for haematopoietic stem cells 
(stem cells that give rise to all blood 
cells). It is argued that this direct con-
nection allows chemical messengers 
known as neurotransmitters (specif-
ically CGRP and substance P) to be 
released from pain fibres to stimulate 
the creation of new blood cells. In Dr. 
Miyan’s own words, “Nerve terminals 
releasing neurotransmitters are open-
ing and closing the doors between the 
bone marrow and the blood, [and] 
nerves going into the bone marrow … 
are controlling haematopoiesis of every 
single type of blood cell in the body 
– therefore, the bone marrow would 
seem to be controlled by neural input.”
 
Pain fibres are also thought to help the 
brain identify what type of host chal-
lenge is attacking the immune system. 
Dr. Miyan and his group have found 
that pain fibres are not only connected 
to stromal cells, but also to Langer-
han’s cells. Langerhan’s cells lie under 
our skin (amongst other places) and 
can ‘present’ bone marrow T-cells with 
antigens. T-cells that have seen this 
antigen before (memory T-cells) will 
divide to create an identical sub-pop-
ulation of cells that also recognise the 
antigen. The long, arm-like extensions 
of T-cells have also been found to 
terminate onto pain fibres, potentially 
allowing T-cells to convey information 
about an antigen back to the brain.
The network of pain fibres around our 
body act as a brain-controlled sensory 
system – stimulating the production of 
blood cells and immune system cells to 
eliminate host challenges.
Diseases: Are they all in your head?
As opposed to a defective immune 
system, recent evidence points the 
finger at the pain fibre sensory sys-
tem as the underlying cause of many 
currently untreatable (or difficult to 
treat) disorders. “For example,” Dr. 
Miyan explains, “for years, people have 
been using stem cells [as treatments] 
to re-populate the bone marrow and 
hope that it [gets rid of the disease], 
but …even though you replace the 
cells, the underlying cause is still there 
and so the disorder comes back.”
Dr. Miyan suspects that these senso-
ry system malfunctions arise in the 
last trimester of pregnancy, when the 
mother’s hypothalamus is establish-
ing the child’s set-points for health 
(Fig. 1). If, in this period, the mother 
becomes ill, the child’s set points are 
affected. This may not always appear as 
an obvious brain defect in a child, but 
may confer a susceptibility to certain 
diseases or conditions when combined 
with genetic predispositions.
Any underlying disease susceptibili-
ties may not appear until adulthood 
because our bodies are able to com-
pensate for the incorrect settings. Just  
children’s bodies can compensate for 
poor health and fitness by changing 
the way the heart and lungs work, 
for instance, so too could our brains 
change to promote normal function-
ality. As we grow older though, these 
compensation mechanisms lose their 
efficacy and our bodies become more 
susceptible to genetic predispositions 
such as diabetes or cancer.
Dr. Miyan proposes that neurolog-
ical disorders such as autism and 
schizophrenia are actually sickness 
behaviours induced in response to a 
genetically pre-disposed condition: “If 
one is born with the ‘wrong settings’ 
…you then get an effect on the brain 
which, in [most] people, would be 
recognised as sickness behaviour. If the 
brain is not developed correctly, this 
sickness behaviour may appear dif-
ferently; for example in the form of a 
neurological disorders such as autism.” 
Part of Dr. Miyan’s current research 
focuses on finding which host chal-
lenges are likely to play a role in caus-
ing autistic symptoms. He and his col-
leagues in the Neuroscience Systems 
Section of research at the University 
of Manchester have recently shown 
that children with autism spectrum 
disorders (at least, every type they have 
tested so far) are susceptible to five 
main host challenges: streptococcal 
infections, viral infections, heavy metal 
and organophosphate toxic loads, and 
gut allergies. 
The research shows that when one 
or more of these host challenges are 
present, “the way the brain func-
tions changes and autistic syndromes 
appear.” When these challenges are 
treated directly, the autistic symp-
toms seem to disappear. However, Dr. 
Miyan stresses that the treatment of 
these challenges does not permanently 
remove the disorder, “the brain nor-
malises” he says, “but the susceptibility 
remains, so the disorder can reappear if 
the infection recurs.”
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Caught in the Present
Not everyone has been willing to em-
brace Dr. Miyan’s findings. “The prob-
lem in this field is that people don’t 
believe it. When we first published 
the bone marrow studies in mice, a 
Norwegian haematology group pub-
lished a paper entitled ‘No Neuronal 
Regulation of Murine Bone Marrow 
Function’ (Benestad et al, 1998), so it 
got buried.”
Benestad et al. (1998) claimed they 
couldn’t find significant evidence 
that neurotransmitters released from 
pain fibres in the bone marrow could 
induce the creation of new blood cells. 
However, several letters-to-the-ed-
itor disputed the Benestad findings. 
The critics suggested that Benestad 
and co-workers had only interpreted 
part of their data, and that they had 
ignored experimental results that did 
demonstrate interaction between bone 
marrow and pain fibres.
Dr. Miyan hopes that this time around 
people will be more open to his re-
search, especially as he has big plans 
for the future.
A Glimpse of the Future
I asked Dr. Miyan what his next steps 
were. He replied, “Two directions: 
firstly, a pill which all pregnant ladies 
will take in the first stage of pregnancy 
that will maximise the brain develop-
ment of the foetus – we’re nearly there; 
and second, to produce preventative 
cures for peripheral system malfunc-
tions, so, for example, leukaemia.” 
The main aim of this pill would be 
to prevent incorrectly determined 
‘set-points’ during brain development, 
hopefully preventing conditions that 
we are genetically predisposed to in 
later life. Currently, Dr. Miyan’s pill is 
in the process of being patented.
It seems likely that this research will 
make a lasting impact on both the 
scientific and the global community. 
Not only does it turn classical ideas 
about neuroscience and immunology 
on their heads, it encourages a holistic 
approach to developing therapies. 
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The Hopes and Heartbreaks of  HIV
Human Immunodeficiency Virus 1 
(HIV-1) changes infected people’s 
lives because it literally becomes a part 
of who you are.
The virus replicates by engineering 
DNA and then splicing it into our 
own genetic structure – permanently 
rewriting our genetic code. When this 
section of DNA is activated, the new 
code tells proteins to manufacture 
HIV viruses instead of crucial immune 
system materials.
Without treatment, the immune sys-
tem starts to fail as HIV-1 infection 
develops into Acquired Immunode-
ficiency Syndrome (AIDS). Without 
a working immune system, death is 
inevitable via infectious disease or 
cancer.
But the path from HIV invasion, to 
HIV reproduction, to AIDS develop-
ment is evidently a multi-step process, 
meaning there are multiple opportuni-
ties to disrupt HIV’s fatal cycle. Thanks 
to highly active anti-retroviral therapy 
(HAART) or just anti-retroviral ther-
apy (ART), HIV infection is no longer 
the early death sentence it appeared to 
be in the 1980s. Treated HIV suffer-
ers can now live long lives (albeit lives 
locked to powerful medications) because 
ART does not cure HIV. It merely 
manages it.
In March 2013, at the 20th Conference 
on Retroviruses and Opportunistic 
Infections, Dr Hannah Gay of the 
University of Mississippi announced 
that a baby had been functionally cured 
of HIV using ART. Against common 
practice, Dr Gay prescribed a full adult’s 
dose of ARTs to the newborn baby, 
reasoning that the likely benefits far 
outweighed any potential toxic conse-
quences. 
Memory T-cells are responsible for 
“remembering” past pathogens, and 
so allow for faster immune response 
times if the invader attacks again. 
HIV can stow away in the body for 
long periods of time precisely because 
it infects these cells. Babies’ memory 
T-cells exhibit more strength in fight-
ing pathogens than adults’ memory 
T-cells, but they also have shorter life-
spans. The idea, then, behind Dr Gay’s 
treatment is that treating a baby early 
enough will block viral replication and 
allow HIV to be eliminated from the 
body before it can infect long-living 
T-memory cells – preventing the 
virus from making hidden, long-term 
reservoirs.
Dr Gay’s method was being touted as 
the eventual solution to the HIV epi-
demic; a real game changer. However, 
to the horror of millions of people 
around the world, it was announced in 
July, 2014 that the ‘Mississippi baby’ 
was no longer in remission. The virus 
had returned.
Despite this setback in the war against 
By Evan Owens
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The Structure of Melettin 
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HIV, scientists are still confident HIV 
will be soon defeated. Bone marrow 
transplants offer the promise of help 
for some people. In 2008, Timothy 
Brown – otherwise known as the 
“Berlin patient” – received a bone 
marrow transplant from a donor who 
held a natural resistance to the virus 
(a resistance possessed by ~1% of the 
population). He was lucky that his 
body accepted the new immune cells 
and successfully fought off the virus, 
however we know that the likelihood 
of finding appropriate bone marrow 
donors for all the people who need 
transplants is extremely small. We can-
not rely on this method as a solution 
to all HIV infections.
Recent research also suggests that 
long-term ART can cause serious 
metabolic issues, and this means re-
search into novel HIV treatments has 
become a high priority.
Scientists from the Washington 
University School of Medicine in St. 
Louis have shown that a peptide called 
melittin can destroy HIV while leaving 
surrounding cells unharmed. Isolated 
from European Honey Bee venom, the 
melittin is loaded onto nanoparticles 
where it fuses to and ruptures the out-
er membrane of HIV particles. Since 
the body’s normal cells are larger than 
HIV cells, specifically shaped mol-
ecules are attached to the outside of 
the nanoparticles. Normal cells simply 
bounce away, but the smaller HIV vi-
ruses still get through to be destroyed 
by the melittin.
The researchers argue that their pro-
cedure is superior to other treatments 
since melittin attacks an intrinsic part 
of HIV’s structure, whereas procedures 
like ART merely inhibit the virus’ 
replication process. Melittin not only 
prevents initial infection but also pro-
vides a tough evolutionary hurdle for 
HIV to overcome; that is, how could 
the virus possibly adapt to not having 
a protective outer membrane?
The research group intend to use 
the method to develop a vaginal gel, 
which will allow healthy contracep-
tion even if one of the partners has 
HIV. Thanks to the built in molecular 
bumpers, sperm would bounce off the 
melittin-loaded nanoparticles while 
the smaller HIV particles would be 
destroyed. Furthermore, melittin does 
not just attack HIV: it will destroy the 
double-membrane of any virus, such as 
hepatitis B and C.
So far, ART based treatments are not 
providing the HIV cure that humanity 
requires. Investigation into novel HIV 
treatments is still necessary. With oth-
er ideas like Wickline’s and colleagues’ 
anti-HIV vaginal gel coming to the 
forefront, we can hope that HIV will 
be, one day, eradicated.
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Undergraduate students, a serious condition plagues our 
honours students – ‘Research Shock!’  This condition is 
rarely mentioned within our lecture theatres and teaching 
laboratories, but if you are considering honours, you need to 
be prepared. 
In 2013 I worked deep undercover to reveal the story about 
the real life of an honours student; my report will help you 
read between the lines of the glossy honours information 
session.
Yes, I have discovered aspects of the honours student’s life 
that may induce Research Shock in the unprepared, but I 
have also found the mystical ‘elixir of honours’ that explains 
why people keep coming back for more. 
Read on...
Long working hours are normal
As the name suggests, ‘honours’ students receive great priv-
ileges every day. Students have the honour of being the first 
person to get to work – when the building is empty and the 
offices are dark – and the last to leave (Figure 1). 
Duties awarded with this honour include unlocking the lab 
door and turning on the lights at the start of the day, and 
then turning off the lights and locking the door at the end 
of the day. Weekends and public holidays become irrelevant 
as your internal clock reschedules to events such as ‘when 
your experiments stop’ and ‘when your next experiment 
begins’. Not rain, nor sunshine, nor gloom of night can stay 
the honours students from their work.
Like a well-trained lab rat, a keen honours student becomes 
an expert in time management, scheduling, and operating 
the vending machine. As for your social life – be prepared 
to make adjustments. Best friend having their 21st birthday 
party? Great! As long as you can leave early to go back to 
the lab. After all, you are running an experiment that uses 
thousands of dollars worth of reagents.
Sleep deprivation is normal
After the long hours spent at uni, an honours student 
doesn’t usually think about partying – the most enticing 
activity in the world is a good sleep. Too few hours of 
sleep creates a ‘sleep-debt’, and honours students are often 
found opportunistically napping in safe territory – like 
under their desk (Figure 2). 
Failure to remove your sleep-debt induces a zombie-like 
state where you carry out your daily tasks with no aware-
ness of what you have (or haven’t) done. This looks bad 
when your supervisor bounces in and asks for an update on 
your progress.  This leads me to my next point. Say hello to 
caffeine! 
Coffee drinking is normal
For students who don’t like coffee, I wish them luck. Cof-
fee (or any suitable caffeine delivery vehicle) is the staple 
drink of the honours student. Undergrads are not always 
aware of how much coffee they will consume during hon-
ours.
Coffee is often consumed with a group of people from 
your lab or fellow honours students (Figure 3). Trips to 
The Real Life of  a Research Student 
This article is dedicated to my fellow honours students, 
whose joys and tears are shared among colleagues and 
friends, and to my supervisor C. R. W. for letting me loiter 
around the lab.
Figure 1. Empty corridors and dark offices are often encountered by 
honours students in the mornings and evenings.
By Jacinta D Kong
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the local café peak at ‘coffee-o’clock’ – 
conventionally known as 3pm.
These trips provide temporary bonuses 
to your productivity and energy levels, 
leaving you fresh and awake (or at least 
awake). The shock comes from the 
realisation of how much money you 
have spent on coffee that week and 
how much money you have left (i.e. 
approaching zero).
Forget the dolphins
Coffee trips are a form of procras-
tination where all participants deny 
the existence of work they need to do. 
Eventually people succumb to their 
guilt though, leading to another cause 
of research-shock: the actual work you 
do for research. 
Research is exciting and you learn 
useful skills. But if you think research 
is all about fun things like playing 
with dolphins, playing with lasers, or 
training laser-wielding dolphins, you 
should think again.
Research requires you to operate as a 
logical, responsible, independent agent 
while at the same time functioning as 
a small but reliable cog within a great-
er research machine. To be a researcher 
you need to think critically, cooperate, 
collaborate, and network.
Labs are always crowded and busy be-
cause there are several people working 
in a small area. To keep things tidy 
and in working order, jobs are shared. 
The simple jobs are essential: the lab 
stops functioning if people stop doing 
the washing, taking out the trash, and 
caring for the study animals, plants or 
cell cultures . 
Sometimes all that is required is to 
wait … and wait … and wait some 
more between stages of your experi-
ments. But waiting is not all bad – all 
that hanging around the lab does give 
you some time to have fun!
Research is fun
My motto is: “a spoonful of sugar 
helps the P-value go down”. Just be-
cause you have a lot of responsibilities 
doesn’t mean that you can’t have fun. 
Sleep-deprivation, for example, makes 
everything funny regardless of context. 
Dreaming of your next experiment or 
talking to your study animals doesn’t 
mean you are crazy; it means you are 
focused. A little too focused. Still, an-
imals, bacteria, and even microscopes 
don’t object to sporadic singing, or 
even to long conversations about their 
life plans. Just don’t fall in love with 
the PCR machine, because the centri-
fuge will get jealous.
Decorating objects in the lab or baking 
to procrastinate (‘procrastibaking’) are 
other examples of fun derived from 
research, and baked goods may be 
shared among members of the lab for 
brownie points (Figure 4). Co-workers 
are always hungry and they appreciate 
free food. 
Research is intense but you are your 
own boss. You can decide exactly when 
you want to work and when you want 
to have fun since you are, of course, a 
powerhouse of self-motivation. You 
may have to come in to uni seven days 
a week but nobody will stop you if you 
go see a movie or even run off to a 
theme park during your quieter days. 
Some people even prefer to come in 
on quiet weekends and pump up some 
music while they work.
The colleagues you meet during 
honours are potentially long-lasting 
friends who can join in the research 
fun with you, help sort out your prob-
lems, and maybe even offer you a job 
somewhere down the line. 
Working in such close proximity to, 
at times, highly-stressed individuals 
means that everyone may not always 
get along. Patience, understanding and 
communication are essential to main-Figure 2. An honours student napping in their natural environment.
Figure 3: Coffee. That is all. 
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taining healthy working relationships, 
but conversations with your co-work-
ers can be extremely amusing (e.g. dis-
cussing your dream Pokémon team or 
assigning Game of Thrones character 
names to your experimental rats). All 
these interactions produce a close-knit 
lab family. Do not be alarmed if you 
get to know your co-workers very, very 
well. 
Supervisors are humans with super-
powers
Supervisors may be your ‘academic 
parents’ but this is not the same as 
being your real parents . They will not 
do your laundry, but they are there to 
support you, keep you on the right 
track and help you when you ask. 
Remember that supervisors are busy 
people with genuine social lives, fam-
ilies and other academic duties. They 
may care deeply for your wellbeing and 
will go out of their way to help you, 
but you cannot expect them to con-
stantly give you their highest priority 
or even know exactly what you have 
been doing. You might be surprised to 
discover you are not the centre of their 
universe and you have to work on your 
own! Conversely, if you are having dif-
ficulty with your work, don’t be afraid 
to approach them or anyone else in the 
lab for help. 
But supervisors can be like cats: you 
can go for days or weeks between 
interactions and you may have no idea 
where and when in space-time they’ve 
disappeared to. Their offices seem 
to exhibit weird quantum behaviour 
(think Schrödinger); until you open 
the door it’s impossible to know 
whether they’re in there or not. This 
only serves to teach you to work out 
problems by yourself and to not be too 
dependent on others. 
Ask for help
Honours is intense and it is full of 
challenges. Despite your apparent 
organisational prowess and your astro-
nomical GPA, you will discover that 
not all experiments work. In fact, every 
researcher has horror stories to share, 
so don’t get too depressed if it looks 
like nothing is working at all! Just keep 
swimming and everything generally 
sorts itself out in the end. 
The important thing is that, as a 
research student, you become a quick 
learner. If you want to stay sane you 
must also develop patience, persever-
ance, and humility. Some students will 
stress more than others, and most stu-
dents feel as if they are running out of 
time. Know that all research students 
are under the same circumstances and 
everyone shares the same pain. Peo-
ple will help you, but you have to ask. 
Don’t wait until it is too late to reach 
out.
Your desk is your home
Research students receive their own 
desk in a shared office. Having your 
own personal space is amazing. It’s a 
great ego-boost to see your name on 
the door and to have your own keys 
to your office and the lab. Your space 
can be customised to reflect your 
personality and stocked with your 
favourite snacks (Figure 5). Desks are 
also a great place to stash a collection 
of pre-worn clothing, sporting equip-
ment, and closed shoes for the lab; 
sometimes they start to smell a little 
lived-in. 
A desk will be inherently messy 
despite your best intentions and may 
even become the victim of office 
pranks by your so-called ‘friends’. A 
computer is generally provided and 
having dual monitors is highly recom-
mended for optimal productivity (I 
need one of my screens to run Face-
book). 
My main problem with my desk? I just 
kept thinking I could do with a bigger 
one!
Struggle brings success
The pain of research, however brutal, 
is soon forgotten when after months 
of junk food, no money, no social life, 
and no holidays, the honours student 
emerges from the lab victorious! 
Part of understanding the joys of 
research and science in general is to 
experience the whole range of emo-
tions that research can create – from 
the highs to the lows. Research 
students receive a disproportionate 
amount of happiness over small things 
like one positive result, the sanctitude 
of a well-deserved sleep-in, or an air 
freshener for their desk.
Figure 4. Depicting research on cakes may 
be shared among the lab and may please 
your supervisor.
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Students who report that their proj-
ect is going along without a hitch 
are treated with incredulity by other 
researchers. Most secretly assume that 
these ‘happy’ students have suffered 
such great mental trauma that they 
have shut down, and are just in denial. 
Perhaps sadly, most of us don’t go 
through honours in a state of denial. 
Instead, people suffer from ‘Imposter 
Syndrome’ – asking themselves ques-
tions like “why am I doing this?” and 
“am I good enough at this to be a sci-
entist?” These personal struggles with 
the voices in your head can really help 
you see what sort of person you are. 
They also help you make some tough 
decisions about your goals because 
you will, at some point, ask yourself 
why you are doing research. Are you 
seeking fame and fortune or chasing 
after knowledge? Are you testing your 
abilities as a person, or trying to prove 
your worth? In your darker moments 
you will ask yourself whether your 
results are worth the struggle. For 
some people the answer is “no”, but for 
others it is a resounding “yes”!
Often it is not until the end of hon-
ours, or later, that you can look back 
and appreciate what you have learnt 
and experienced. Full-time researchers 
often reminisce that their honours year 
was simultaneously the most stressful 
and the most rewarding in all their 
years of research. 
The final message
Ultimately, what it comes down to 
in honours is that people around you 
don’t know the answer to your research 
question. Instead, you are at the edge 
of the field of knowledge, and rather 
than being ‘just a student’ you are, 
finally, the expert. 
As part of the journey you might 
make friends with your equipment, 
and you’ll definitely get to know some 
great people. But most importantly 
of all, you’ll get to know yourself, and 
discover just how much you can do. 
Go for it undergraduates – expose 
yourselves to Research Shock!
Figure 5. A typical messy drawer of an honours student.
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On the Lighter Side
Plenty of famous discoveries were real-
ised due to abnormalities in data – the 
microwave, penicillin and plastic were 
all invented by accident, for instance. 
History has rewarded scientists who 
keep their eyes and minds open, and 
sometimes this means actively pursu-
ing the unconventional and bizarre. 
This article explores some scientists’ 
serious, though strange, research 
findings, which may help us when we 
sit to ponder the meaning of life, the 
universe and everything.
Chimps know their butts – the results 
don’t lie!  You other scholars shan’t 
deny.
The first entry into this group of 
notable, peer-reviewed scientific 
publications is the winner of the 2012 
Ig Nobel prize for Anatomy. The Ig 
Nobel Prizes are parodies of the Nobel 
Prizes, and are intended to celebrate 
unusual and imaginative and interests 
in science, medicine, and technology. 
Research by de Waal and Pokorny 
(2008) was able to discern a trait in 
adult chimpanzees (Pan troglodytes) 
hopefully lost to humans early in our 
evolutionary divergence. 
In a study that would leave Dr. Zira 
from Planet of the Apes red-faced, 
‘Faces and Behinds: Chimpanzee Sex 
Perception’ summarises how chim-
panzees can identify other individual 
chimps based on photographs each 
other’s rear ends. Trained on comput-
ers, subjects made the correct associ-
ation for familiar individuals but not 
unfamiliar ones – suggesting whole-
body knowledge of group mates. 
However enlightening this paper on 
chimp psychology may be, it may not 
necessarily apply to humans. Cau-
tion should always be exercised when 
commenting on the posterior of your 
significant other – always.
Swimming – delicious swimming…
 ‘Will Humans Swim Faster or Slower 
in Syrup?’ Gettelfinder and Cussler 
(2004) settled this longstanding scien-
tific dilemma by investigating how a 
pool filled with guar gum – compared 
to a water-filled pool – affected the 
times of sixteen swimmers (ten com-
petitive and six recreational). Guar-
gum has a viscosity with about twice 
that of water, and is synthesised from 
the guar bean.
Surprisingly, the results showed that 
the swimming speeds in the guar 
solution were the same as those in the 
water. The extra friction force (drag) 
experienced in the guar-gum was 
cancelled out by the increased thrust 
achieved by each swimming stroke. 
Evidently, the higher the viscosity of a 
fluid, the more force you can generate 
by pushing back against it.
For a human-sized body, the authors 
calculate that drag starts to slow down 
The most exciting phrase to hear in science, the one that heralds new discoveries, is not “Eureka! (I’ve found it)”, but, 




swimming times when the swimming 
medium is approximately one-thou-
sand times more viscous than water. 
Only then would drag start to domi-
nate over the increased thrust of each 
stroke.
 Hard facts on soft matter!
In 1992, Ian Osterloh and his team 
were trialling a drug that expands 
blood vessels to treat angina called, at 
the time, UK-92480. The drug reten-
tion for UK-92480 was low; therefore, 
it needed to be taken three times a day 
to maintain a constant effect. During 
the drug trials, male volunteers ap-
parently reported increased erections 
several days after the initial dose. Not 
much attention was given to this side 
effect at the time.
In a statement that Osterloh gave 
COSMOS magazine, he postulated, 
“Who would want to take a drug on 
a Wednesday to get an erection on 
a Saturday?” However, other stud-
ies conducted around the same time 
helped his team understand why they 
were increasingly getting reports from 
their male candidates. The delay in 
effect was later resolved, and the drug 
was marketed – our junk email folders 
stand as constant testimonial to the 
drug’s success.
 Navel-gazing
The opener to Steinhauser’s (2009) 
insightful paper, ‘The Nature Of 
Navel Fluff ’,  hypothesises  that men’s 
abdominal hair collects cotton fibres 
from shirts and transports them into 
the navel by normal body movement. 
It was hypothesised that this acted 
as a cleaning function for the navel. 
Roughly three years and 503 samples 
later, the evidence seemingly support-
ed his guess. 
Elemental analyses showed that the 
originally pure cellulose fibres were 
contaminated with foreign materials – 
including house dust, cutaneous scales, 
fat, proteins, and sweat. The author 
refers to papers such as Ene-Parent 
and Zikovsky (2001) who did their 
paper on ‘Neutron Activation Analysis 
Of Laundry Dryer Lint’ to highlight 
lint’s absorbent properties. Supposedly, 
generating navel fluff and then remov-
ing it leaves its proud owner with a 
comparatively cleaner navel.
Penguin projectiles
“Anyone who has then watched a 
penguin fire a ‘shot’ from its rear end 
must have wondered about the pres-
sure the bird generates” – a question 
for the ages that drove Meyer-Ro-
chow and Gal (2003) to calculate the 
likely pressures involved in ‘venting’ by 
Chinstrap and Adélie  penguins. 
Their paper, ‘Pressures Produced 
When Penguins Pooh – Calculations 
on Avian Defecation’, explores the 
fluid dynamics relating to the whitish 
or pinkish streak that ends up a few 
centimetres from the periphery of the 
bird’s nest. 
Due to the protected nature of 
penguins and the restrictions on 
approaching them, the researchers 
utilised a few ‘spot-on’ photographs 
and the Hagan-Poiseuille-equation 
for dynamic pressure to estimate the 
aperture from which the semi-liq-
uid excretions were released.  Using 
spatial location and previous ana-
tomical studies on the birds, they 
were then able to calculate that fully 
grown penguins generate pressures 
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of around 10 kPa (77 mm Hg) to expel watery material and 
60 kPa (450 mm Hg) to expel material of higher viscosities 
(not too dissimilar to olive oil). 
To put that into perspective, 60 kPa is close to the pressure 
that paint exits from a low-pressure paint spray gun. This 
peculiar feature is most likely an evolutionary trait that 
allows the penguins to defecate during the brooding season, 
without leaving their nests unguarded. 
Cheesy science
In an experiment that any physicist could replicate during 
their lunch breaks, Mulet et al. (1999) makes us hungry 
in their paper: ‘Ultrasonic Velocity in Cheddar Cheese as 
Affected by Temperature’. At first glance this paper may 
be misinterpreted as an analysis conducted by a physicist 
competing in the Gloucester Cheese Rolling competition – 
where contestants roll a cheese from the top of a steep hill, 
and then run after it – but as entertaining as it would be to 
watch people chase a cheese rolling at ultrasonic velocities, 
this was sadly not the case. 
Ultrasonic velocity is the speed in which sound above 
human hearing (>20,000Hz) propagates through a certain 
material. Using two ultrasonic devices, it was determined 
that at 0°C the ultrasonic velocity was 1590 m/s and then 
at 35°C was 1696 m/s. Furthermore, the most reliable 
temperature interval to carry out ultrasonic measurements 
in Cheddar cheese was identified as 0°C to 17 °C. The 
researchers believed that these findings might help cheese 
makers detect structural defects in cheese, and determine 
cheese maturity and cut-time.
Reporting Reporting Reports
A notable mention also to The US Government General 
Accountability Office for winning the 2012 Ig Nobel Prize 
for Literature. Their report about reports about reports that 
recommends the preparation of a report about the report 
about reports about reports is a highly recommended read 
to any person wishing to prepare a report complaining 
about this report. 
All comics in this article were created by freelance artist 
Ryan Cooper.  To contact him please email 
ryanjohncooper@gmail.com 
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